These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 10789073)

  • 21. Formulation and evaluation of bi-layer tablet of metoclopramide hydrochloride and ibuprofen.
    Shiyani B; Gattani S; Surana S
    AAPS PharmSciTech; 2008; 9(3):818-27. PubMed ID: 18612830
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Formulation and optimization of floating matrix tablets of clarithromycin using simplex lattice design.
    Singh I; Saini V
    Pak J Pharm Sci; 2016 Mar; 29(2):511-9. PubMed ID: 27087096
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of novel diclofenac potassium controlled release tablets by wet granulation technique and the effect of co-excipients on in vitro drug release rates.
    Shah S; Khan GM; Jan SU; Shah K; Hussain A; Khan H; Khan H; Khan H; Khan KA
    Pak J Pharm Sci; 2012 Jan; 25(1):161-8. PubMed ID: 22186325
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimization of propranolol hydrochloride sustained-release pellets using box-behnken design and desirability function.
    Bodea A; Leucuta SE
    Drug Dev Ind Pharm; 1998 Feb; 24(2):145-55. PubMed ID: 15605444
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of different polymers and their combinations on the release of metoclopramide HCl from sustained-release hydrophilic matrix tablets.
    Savaşer A; Taş Ç; Bayrak Z; Özkan CK; Özkan Y
    Pharm Dev Technol; 2013; 18(5):1122-30. PubMed ID: 22881478
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development and Optimization of Gastro-Retentive Controlled-Release Tablet of Calcium-Disodium Edentate and its In Vivo Gamma Scintigraphic Evaluation.
    Kumar N; Soni S; Singh T; Kumar A; Ahmad FJ; Bhatnagar A; Mittal G
    AAPS PharmSciTech; 2015 Dec; 16(6):1270-80. PubMed ID: 25771737
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preparation and in vitro/in vivo evaluation of sustained-release venlafaxine hydrochloride pellets.
    Liu Y; Sun Y; Sun J; Zhao N; Sun M; He Z
    Int J Pharm; 2012 Apr; 426(1-2):21-28. PubMed ID: 22266529
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Application of similarity factor in development of controlled-release diltiazem tablet.
    Peh KK; Wong CF
    Drug Dev Ind Pharm; 2000 Jul; 26(7):723-30. PubMed ID: 10872090
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro release of metoclopramide from hydrophobic matrix tablets. influence of hydrodynamic conditions on kinetic release parameters.
    Frutos P; Pabón C; Lastres JL; Frutos G
    Chem Pharm Bull (Tokyo); 2001 Oct; 49(10):1267-71. PubMed ID: 11605652
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The influence of drug type on the release profiles from Surelease-coated pellets.
    Sadeghi F; Ford JL; Rajabi-Siahboomi A
    Int J Pharm; 2003 Mar; 254(2):123-35. PubMed ID: 12623188
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development and optimization of press coated tablets of release engineered valsartan for pulsatile delivery.
    Shah S; Patel R; Soniwala M; Chavda J
    Drug Dev Ind Pharm; 2015; 41(11):1835-46. PubMed ID: 25721985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optimization of tamsulosin hydrochloride controlled release pellets coated with Surelease and neutralized HPMCP.
    Kim MS; Kim JS; Lee S; Jun SW; Park JS; Woo JS; Hwang SJ
    J Pharm Pharmacol; 2006 Dec; 58(12):1611-6. PubMed ID: 17331324
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A simple and rapid approach to evaluate the in vitro in vivo role of release controlling agent ethyl cellulose ether derivative polymer.
    Akhlaq M; Khan GM; Jan SU; Wahab A; Hussain A; Nawaz A; Abdelkader H
    Pak J Pharm Sci; 2014 Nov; 27(6):1789-98. PubMed ID: 25362603
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of an Abuse- and Alcohol-Resistant Formulation Based on Hot-Melt Extrusion and Film Coating.
    Jedinger N; Schrank S; Fischer JM; Breinhälter K; Khinast J; Roblegg E
    AAPS PharmSciTech; 2016 Feb; 17(1):68-77. PubMed ID: 26206403
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimization of pH-independent release of nicardipine hydrochloride extended-release matrix tablets using response surface methodology.
    Huang YB; Tsai YH; Lee SH; Chang JS; Wu PC
    Int J Pharm; 2005 Jan; 289(1-2):87-95. PubMed ID: 15652202
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Formulation development and investigation of ibuprofen controlled release tablets with hydrophilic polymers and the effect of co-excipients on drug release patterns.
    Jan SU; Khan GM; Hussain I
    Pak J Pharm Sci; 2012 Oct; 25(4):751-6. PubMed ID: 23009990
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Controlled release matrix tablets of glipizide: Influence of different grades of ethocel and Co-excipient on drug release.
    Mehsud SU; Khan GM; Hussain A; Akram M; Akhlaq M; Khan KA; Shakoor A
    Pak J Pharm Sci; 2016 May; 29(3):779-87. PubMed ID: 27166548
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of artificial neural networks to predict drug dissolution profiles and evaluation of network performance using similarity factor.
    Peh KK; Lim CP; Quek SS; Khoh KH
    Pharm Res; 2000 Nov; 17(11):1384-8. PubMed ID: 11205731
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and in vitro evaluation of oral controlled release formulations of celecoxib using optimization techniques.
    Chandran S; Ravi P; Saha RN
    Yakugaku Zasshi; 2006 Jul; 126(7):505-14. PubMed ID: 16819273
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preparation and in-vitro evaluation of sustained-release metoclopramide hydrochloride microspheres.
    Khidr SH; Niazy EM; el-Sayed YM
    J Microencapsul; 1995; 12(6):651-60. PubMed ID: 8558387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.